| Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors (NCT01608152) | M.D. Anderson Cancer Center | 2013-02-20 |
| Indenoisoquinoline LMP400 for Advanced Solid Tumors and Lymphomas (NCT01794104) | National Cancer Institute (NCI) | 2013-02-15 |
| CD5789 in Early Cutaneous T-Cell Lymphoma (CTCL) (NCT01804335) | M.D. Anderson Cancer Center | 2013-02-01 |
| Longitudinal Sexual and Reproductive Health Study of Women With Breast Cancer and Lymphoma (NCT01788839) | Memorial Sloan Kettering Cancer Center | 2013-02-01 |
| Mass Balance, Pharmacokinetics and Metabolism Study of Alisertib (NCT01714947) | Millennium Pharmaceuticals, Inc. | 2013-01-24 |
| Cytotoxic T-Lymphocytes for EBV-positive Lymphoma, GRALE (NCT01555892) | Baylor College of Medicine | 2013-01-14 |
| Collecting and Studying Tissue Samples From Patients With HIV-Associated Malignancies (NCT01567722) | AIDS Malignancy Consortium | 2013-01-02 |
| Zevalin-Containing Nonmyeloablative Conditioning for Stem Cell Transplantation (SCT) (NCT01490723) | M.D. Anderson Cancer Center | 2013-01-01 |
| Infusion of Allogeneic Umbilical Cord Blood-Derived Cluster of Differentiation Antigen 19 (CD19)-Specific T Cells (NCT01362452) | M.D. Anderson Cancer Center | 2012-12-07 |
| Study of Hypotensive Hematopoietic Malignancy Patients' USCOM Readings (NCT01755000) | Washington University School of Medicine | 2012-12-01 |
| Bendamustine in Acute Lymphoblastic Leukemia/Lymphoma (ALL) (NCT01649622) | M.D. Anderson Cancer Center | 2012-12-01 |
| Lenalidomide After Allo Transplant (NCT01750762) | Beth Israel Deaconess Medical Center | 2012-12-01 |
| Study to Assess the Safety, Tolerability and Pharmacokinetics of Fimepinostat (CUDC-907) in Patients With Lymphoma (NCT01742988) | Curis, Inc. | 2012-12-01 |
| Clinical Cohort of Lymphoma Patients in Malawi (NCT02835911) | UNC Lineberger Comprehensive Cancer Center | 2012-11-01 |
| Intrabone Transplantation of Allogenic Peripheral Blood Stem Cells in Patients With Myeloid and Lymphoid Malignancies. (NCT01728389) | Maria Sklodowska-Curie National Research Institute of Oncology | 2012-11-01 |
| Comparison of "Wet Suction" Technique to Contemporary "Dry Suction" Technique Using a 22 Gauge Needle for EUS FNA (NCT01720745) | University of Minnesota | 2012-10-01 |
| A Study of LY3039478 in Participants With Advanced Cancer (NCT01695005) | Eli Lilly and Company | 2012-10-01 |
| A RETROspective Data Collection of comPRESSion Anastomosis Using the ColonRing (NCT01880918) | novoGI | 2012-10-01 |
| Polymorphism of the IgH Locus Regulatory Region as a Prognostic Factor During Immune Pathologies. (NCT01715623) | University Hospital, Limoges | 2012-10-01 |
| Cord Blood With T-Cell Depleted Haplo-identical Peripheral Blood Stem Cell Transplantation for Hematological Malignancies (NCT01682226) | Memorial Sloan Kettering Cancer Center | 2012-09-05 |
| A Phase I Study: PET Imaging of Cancer Patients Using [18F] 4-L-Fluoroglutamine (2S,4R) (NCT01697930) | Memorial Sloan Kettering Cancer Center | 2012-09-01 |
| Combination Chemotherapy With or Without Autologous Stem Cell Transplant in Treating Patients With Central Nervous System B-Cell Lymphoma (NCT01511562) | Alliance for Clinical Trials in Oncology | 2012-09-01 |
| A Study of CD45RA+ Depleted Haploidentical Stem Cell Transplantation in Children With Relapsed or Refractory Solid Tumors and Lymphomas (NCT01625351) | St. Jude Children's Research Hospital | 2012-08-20 |
| Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma (NCT01415752) | Eastern Cooperative Oncology Group | 2012-08-09 |
| Fluorodeoxyglucose Imaging Studies to Detect Lymphoma (NCT01672918) | National Institute of Allergy and Infectious Diseases (NIAID) | 2012-08-06 |
| Romidepsin in Treating Patients With Lymphoma, Chronic Lymphocytic Leukemia, or Solid Tumors With Liver Dysfunction (NCT01638533) | National Cancer Institute (NCI) | 2012-08-03 |
| A Study of the HSP90 Inhibitor AUY922 (NCT01485536) | M.D. Anderson Cancer Center | 2012-08-01 |
| Conventional Versus Ultrasound-guided Transbronchial Needle Aspiration for the Diagnosis of Hilar/Mediastinal Lymphadenopathies (NCT01658280) | Azienda Ospedaliero, Universitaria Ospedali Riuniti | 2012-08-01 |
| Cord Blood Fucosylation to Enhance Homing and Engraftment in Patients With Hematologic Malignancies (NCT01471067) | M.D. Anderson Cancer Center | 2012-07-13 |
| A Study of LY2875358 in Japanese Participants With Advanced Cancer (NCT01602289) | Eli Lilly and Company | 2012-06-01 |
| Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis (NCT01441089) | National Cancer Institute (NCI) | 2012-05-21 |
| Safety and Pharmacokinetic Profile of CKD-581 (NCT01580371) | Chong Kun Dang Pharmaceutical | 2012-05-01 |
| Continuous Infusion of rhIL-15 for Adults With Advanced Cancer (NCT01572493) | National Cancer Institute (NCI) | 2012-04-04 |
| A Pilot Study of Recombinant Human Arginase 1 (rhArg1) in Patients With Relapsed or Refractory Leukemia or Lymphoma (NCT01551628) | Bio-Cancer Treatment International Limited | 2012-04-01 |
| Evaluation of 64Cu-DOTA-U3-1287 in Subjects With Advanced Solid Tumors (NCT01479023) | Washington University School of Medicine | 2012-04-01 |
| Maintenance Lenalidomide in Lymphoma (NCT01575860) | Abramson Cancer Center at Penn Medicine | 2012-04-01 |
| A Open-Label, Multiple Ascending Dose Study of DS-3078a, an Oral TORC1/2 Kinase Inhibitor, in Subjects With Advanced Solid Tumors or Lymphomas (NCT01588678) | Daiichi Sankyo | 2012-04-01 |
| Everolimus, Rituximab, and Combination Chemotherapy in Treating Patients With Newly Diagnosed Untreated Diffuse Large B-Cell Lymphoma (NCT01334502) | Alliance for Clinical Trials in Oncology | 2012-03-01 |
| Clinical Ex Vivo Expansion of Human Umbilical Cord Blood Stem and Progenitor Cells (NCT01624701) | Singapore General Hospital | 2012-03-01 |
| Immune Reconstitution in Oncology Patients Following Autologous Stem Cell Transplant (NCT01540175) | St. Jude Children's Research Hospital | 2012-03-01 |
| Imetelstat for Children With Refractory or Recurrent Solid Tumors and Lymphoma (NCT01568632) | National Cancer Institute (NCI) | 2012-03-01 |
| A Two-Step Approach to Bone Marrow Transplant Using Cells From Two Partially-Matched Relatives (NCT01532635) | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | 2012-03-01 |
| Busulfan-fludarabine Conditioning and T-cell Depleted Allogeneic Stem Cell Transplantation for Patients With Advanced Hematologic Malignancies (NCT00943319) | University of Chicago | 2012-03-01 |
| Phase 1/2, Open-label, Dose-escalation Study of IONIS-STAT3Rx, Administered to Patients With Advanced Cancers (NCT01563302) | Ionis Pharmaceuticals, Inc. | 2012-02-27 |
| Biomarkers in Predicting Response to Rituximab Treatment in Samples From Patients With Indolent Follicular Lymphoma (NCT01381705) | ECOG-ACRIN Cancer Research Group | 2012-02-06 |
| Positron Emission Tomography/Magnetic Resonance Imaging in Patients (NCT01557881) | Case Comprehensive Cancer Center | 2012-02-01 |
| Samsung Medical Center-Lymphoma Cohort Study-II (NCT01877109) | Samsung Medical Center | 2012-02-01 |
| Planned Donor Lymphocyte Infusion (DLI) After Allogeneic Stem Cell Transplantation (SCT) (NCT01518153) | M.D. Anderson Cancer Center | 2012-02-01 |
| Testing a Spanish Version of a Patient Toxicity Questionnaire (NCT01517152) | National Cancer Institute (NCI) | 2012-01-04 |
| Application of Telemedicine to the Management of Aggressive Lymphomas (NCT03336138) | University Hospital, Toulouse | 2012-01-01 |
| Establishing Prospective Mediastinal Tumor Database of PUMCH (NCT06421805) | Peking Union Medical College Hospital | 2012-01-01 |
| Salvage Therapy With High Dose Oral Clarithromycin in Relapsed or Refractory Extranodal Marginal Zone Lymphoma (NCT01516606) | Andres J. M. Ferreri | 2012-01-01 |
| Gene Expression in Samples From Patients With T-Cell Acute Lymphoblastic Leukemia (NCT01520246) | Children's Oncology Group | 2012-01-01 |
| Biomarkers in Tissue Samples From Patients With Hodgkin Lymphoma Enrolled on ECOG-2496 Clinical Trial (NCT01505712) | ECOG-ACRIN Cancer Research Group | 2011-12-15 |
| DNA Analysis in Influencing Response to Rituximab in Samples From Patients With Follicular Lymphoma Treated on ECOG-E4402 (NCT01406782) | Eastern Cooperative Oncology Group | 2011-12-13 |
| Combination of Lenalidomide and Rituximab in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL-SLL) (NCT01446133) | M.D. Anderson Cancer Center | 2011-12-12 |
| Phase I Study of CS-7017 and Bexarotene (NCT01504490) | Georgetown University | 2011-12-01 |
| Biomarkers in Blood and Tissue Samples From Patients With Epstein-Barr Virus-Positive Hodgkin Lymphoma (NCT01490801) | Children's Oncology Group | 2011-12-01 |
| Pharmacokinetics Study of Oral IXAZOMIB in Participants With Advanced Nonhematologic Malignancies or Lymphoma (NCT01454076) | Millennium Pharmaceuticals, Inc. | 2011-11-10 |
| Donor Lymphocyte Infusion After Stem Cell Transplant in Treating Patients With Haematological Cancers (NCT01240525) | University College, London | 2011-11-01 |
| S1106 Rituximab With Combination Chemotherapy or Bendamustine Hydrochloride Followed by Consolidation Chemotherapy and Stem Cell Transplantation in Older Patients With Previously Untreated Mantle Cell Lymphoma (NCT01412879) | SWOG Cancer Research Network | 2011-11-01 |
| A Study of Investigational SAR245409 in Patients With Certain Lymphoma or Leukemia (NCT01403636) | Sanofi | 2011-10-01 |
| Study of CC-122 to Evaluate the Safety, Tolerability, and Effectiveness for Patients With Advanced Solid Tumors, Non-Hodgkin's Lymphoma, or Multiple Myeloma (NCT01421524) | Celgene | 2011-09-12 |
| AZD1152 in Diffuse Large B-cell Lymphoma (NCT01354392) | Oxford University Hospitals NHS Trust | 2011-09-01 |
| Allogeneic Transplant in HIV Patients (BMT CTN 0903) (NCT01410344) | Medical College of Wisconsin | 2011-09-01 |
| EUS-guided Fine Needle Biopsy With a New Core Histology Needle Versus Conventional Fine Needle Aspiration (NCT01774162) | University of Alberta | 2011-09-01 |
| Longitudinal Survey Analysis in Lymphoma Survivors (NCT01469754) | Weill Medical College of Cornell University | 2011-09-01 |
| In Vitro Expanded Allogeneic Epstein-Barr Virus Specific Cytotoxic T-Lymphocytes (EBV-CTLs) Genetically Targeted to the CD19 Antigen in B-cell Malignancies (NCT01430390) | Memorial Sloan Kettering Cancer Center | 2011-09-01 |
| Rituximab, Methotrexate, Vincristine Sulfate, Procarbazine Hydrochloride, and Cytarabine With or Without Radiation Therapy in Treating Patients With Primary Central Nervous System Lymphoma (NCT01399372) | Radiation Therapy Oncology Group | 2011-09-01 |
| CD34+Selection for Partially Matched Family or Matched Unrelated Adult Donor Transplant (NCT01049854) | New York Medical College | 2011-09-01 |
| S1001 PET-Directed Therapy in Treating Patients With Limited-Stage Diffuse Large B-Cell Lymphoma (NCT01359592) | SWOG Cancer Research Network | 2011-09-01 |
| Chemotherapy Plus Ofatumumab Followed by G-CSF for Mobilization of Peripheral Blood Stem Cells in Patients With Non-Hodgkin's Lymphomas (NCT01329900) | M.D. Anderson Cancer Center | 2011-08-22 |
| Concurrent School Attendance And Cancer Therapy: The Experiences of 6-12 Year Old Pediatric Oncology Patients (NCT01383473) | St. Jude Children's Research Hospital | 2011-08-01 |
| Ofatumumab in Treating Patients With Previously Untreated Stage II, Stage III, or Stage IV Follicular Non-Hodgkin Lymphoma (NCT01190449) | Alliance for Clinical Trials in Oncology | 2011-08-01 |
| Vorinostat With Gemcitabine, Busulfan, and Melphalan With Stem Cell Transplant (SCT) in Relapsed or Refractory Lymphoid Malignancies (NCT01421173) | M.D. Anderson Cancer Center | 2011-08-01 |
| Assessment of Cognitive Function in Breast Cancer and Lymphoma Patients Receiving Chemotherapy (NCT01382082) | University of Rochester NCORP Research Base | 2011-07-14 |
| Ofatumumab for Minimal Residual Disease (MRD) and Maintenance Therapy (NCT01258933) | M.D. Anderson Cancer Center | 2011-07-06 |
| The First-in-human Phase I Trial of PU-H71 in Patients With Advanced Malignancies (NCT01393509) | Memorial Sloan Kettering Cancer Center | 2011-07-06 |
| R-CVP for the Treatment of Non-conjunctival Ocular Adnexal MALT Lymphoma (OAML) (NCT01427114) | Konkuk University Medical Center | 2011-07-01 |
| Myloablative Cord Blood Transplant in Haematological Malignancies (MAC UCBT) (NCT02310997) | University College, London | 2011-07-01 |
| Low-dose Radiotherapy for Diffuse Large B-cell Lymphoma (NCT02803840) | Centro di Riferimento Oncologico - Aviano | 2011-07-01 |
| Phase III Study of Lenalidomide and Dexamethasone With or Without Elotuzumab to Treat Relapsed or Refractory Multiple Myeloma (NCT01239797) | Bristol-Myers Squibb | 2011-06-20 |
| CD19-specific T Cell Infusion in Patients With B-Lineage Lymphoid Malignancies (NCT00968760) | M.D. Anderson Cancer Center | 2011-06-20 |
| High-Dose Gemcitabine, Busulfan and Melphalan for Patients With Refactory Hodgkin's Disease (NCT01200329) | M.D. Anderson Cancer Center | 2011-06-01 |
| SGN-35 in CD30-positive Lymphoproliferative Disorders (ALCL), Mycosis Fungoides (MF), and Extensive Lymphomatoid Papulosis (LyP) (NCT01352520) | M.D. Anderson Cancer Center | 2011-06-01 |
| Study of Blood and Tissue Samples in Children With Newly Diagnosed Acute Lymphoblastic Leukemia (NCT01185886) | European Organisation for Research and Treatment of Cancer - EORTC | 2011-06-01 |
| Stage I/II Nasal NK Cell Lymphoma (NCT01321008) | M.D. Anderson Cancer Center | 2011-05-01 |
| A Rollover Study for Patients Who Participated in Other Romidepsin Protocols (NCT01353664) | Celgene | 2011-05-01 |
| Bortezomib-based GVHD Prophylaxis After Allogeneic Transplant for Patients Without Matched Related Donors (NCT01323920) | Dana-Farber Cancer Institute | 2011-05-01 |
| Imetelstat Sodium in Treating Young Patients With Refractory or Recurrent Solid Tumors or Lymphoma (NCT01273090) | Children's Oncology Group | 2011-05-01 |
| Evolution of Cellular and Viral Resistance in HIV-infected Patients With Lymphoma (NCT01330342) | St Stephens Aids Trust | 2011-05-01 |
| Biomarker Expression in Samples From Young Patients With Anaplastic Large Cell Lymphoma (NCT01366170) | Children's Oncology Group | 2011-05-01 |
| Early Rehabilitation of Cancer Patients (NCT01588262) | Haukeland University Hospital | 2011-05-01 |
| Protein Biomarker Levels in Tissue Samples From Young Patients With Low-risk Hodgkin Lymphoma (NCT01366157) | Children's Oncology Group | 2011-05-01 |
| PU-H71 in Patients With Solid Tumors and Low-Grade Non-Hodgkin's Lymphoma That Have Not Responded to Standard Treatment (NCT01581541) | National Cancer Institute (NCI) | 2011-04-26 |
| AMG 319 Lymphoid Malignancy FIH (NCT01300026) | Amgen | 2011-04-01 |
| Rasburicase in Patients at High Risk for Tumor Lysis Syndrome (TLS) During Cycle-2 (NCT01200485) | M.D. Anderson Cancer Center | 2011-04-01 |
| Open Label Extension Study of Conatumumab and Ganitumab (AMG 479) (NCT01327612) | Amgen | 2011-03-03 |
| Analysis of Data Collected in the European Group for Blood and Marrow Transplantation (EBMT) Registry on a Cohort of Patients Receiving Plerixafor (NCT01362972) | Genzyme, a Sanofi Company | 2011-03-01 |
| Bendamustine Hydrochloride and Rituximab With or Without Bortezomib Followed by Rituximab With or Without Lenalidomide in Treating Patients With High-Risk Stage II, Stage III, or Stage IV Follicular Lymphoma (NCT01216683) | ECOG-ACRIN Cancer Research Group | 2011-02-09 |